Clinical Trial Update: Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating clarithromycin-based bismuth quadruple therapy for Helicobacter pylori infection in patients with functional dyspepsia or peptic ulcers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Drugs mentioned

• Bismuth-containing quadruple therapy
• clarithromycin (clarithromycin)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Functional Dyspepsia, Peptic Ulcer | Phase 4 | Status: COMPLETED